As a consequence, Cannabis Science is entitled to substantial licensing fees and royalties, rights to assign assets and fees to affiliates and subsidiaries, and ownership of all tangible assets such as land, facilities and equipment as well as new business ventures pursuant to the agreement. Cannabis Science, in turn, will provide Apothecary Genetics with quarterly working capital to develop and expand operations, including the provision of research and development facilities.
"This is exciting news for the long-term benefit of patients, as the Company not only will be able to enter into opt-in programs for the evaluation of our proprietary formulations but also will be able to promote advanced medical cannabis R & D," said Mr. Dabney. "And now Cannabis Science will harness the strength of 100% of all the previous and accumulated assets to make a real difference."
The Company will inform the public as each step of its new blueprint for California is realized.